InvestorsHub Logo

H1C

Followers 1
Posts 91
Boards Moderated 0
Alias Born 02/20/2018

H1C

Re: BuddyLou post# 5366

Wednesday, 04/11/2018 3:55:06 PM

Wednesday, April 11, 2018 3:55:06 PM

Post# of 18220
Yeah I think that we'll be stuck with this smothering of any up move in price, until IMUN retires outstanding convertibles, and does not have to issue new notes or shares to cover operating expenses.

We will have to be patient: either for big follow-on orders or new country approvals; or for approval to sell to USAID. 10-K mentioned that they applied for this; don't have time to look up page # right now. But if USAID buys Lodonal from IMUN, that would be big. Low-income countries could get Lodonal as part of an aid package. Projected USAID grant budget for 2019 is $16.8 B. If approved, IMUN could be looking at $MM's in orders by USAID for Lodonal.

https://www.usaid.gov/results-and-data/budget-spending

I'm glad Cytocom has or will get funding on its own for the phase 3 trials. No more IMUN debt/dilution to pay for the trials.